谈球吧官网生物制药股份有限公司

CN

CN EN

精益制药·精益用药·守护健康

Combined Clostridium Butyricum and Bifidobacterium Capsules/Powders, Live

An exclusive probiotic product available to the old, the young, as well as pregnant and lying-in women

Human Erythropoietin Injection

A clinical first-line drug and an industry-leading product for the treatment of anemia in many fields

Human Granulocyte Colony-stimulating Factor
Injection

A clinical first-line drug for prevention and treatment of neutropenia after tumor chemoradiotherapy

Products

A Leader in High Quality Biopharmaceuticals

Kexing Culture

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution

On the evening of August 18, 2022, Kexing Biopharm...

Media Center

Information for medical professionals only.

All contents Copyrights 2019 Kexing Biopharm.(Lu) ICP Reg No.: 59881483 Powered by vancheer

All rights reserved Legal Statement Contact Us

Internet Drug Information Service Certificate Number: (Lu)-non-commercial-2018-0066

All contents Copyrights 2019 Kexing Biopharm.(Lu) ICP Reg No.: 59881483 Powered by vancheer

谈球吧官网-不凡成就非凡主页

友情链接：抖音优酷央视人人网 QQ音乐东方财富 4399小游戏